For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230728:nRSb6268Ha&default-theme=true
RNS Number : 6268H Nanoco Group PLC 28 July 2023
28 July 2023
NANOCO GROUP PLC
("Nanoco", the "Group" or the "Company")
Exercise of Options and Issue of Shares to Employee Benefit Trust
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY
Nanoco announces that it has issued 1,985,206 new Ordinary Shares of 10 pence
each in the Company ("Ordinary Shares"). All of the shares were issued at par
value, pursuant to a subscription by the Company's Employee Benefit Trust
('EBT') to satisfy share awards granted to employees under the Company's
shareholder approved Deferred Bonus Plan. The issue of new shares enables the
company to provide the shares without any cash cost and minimal dilution to
existing shareholders.
On 26 July 2023 Nanoco Group plc ("Nanoco") received notice that Brian Tenner,
CEO, was exercising in full options granted to him in October and December
2019. Mr Tenner's entire bonus award for the financial year ending 31 July
2019 had been issued as deferred share options which were then subject to a
two year holding period. The options vested in full in October and December
2021. Details of the exercise are shown in the table below.
On 26 July 2023 Nanoco received notice that Dr Nigel Pickett, CTO, was
exercising in full options granted to him in October and December 2019. Dr
Pickett's entire bonus award for the financial year ending 31 July 2019 had
been issued as deferred share options which were then subject to a two year
holding period. Dr Pickett has also exercised options granted to him in
November 2016 in respect of the deferred bonus award for the financial year
ending 31 July 2016 and which were also then subject to a two year holding
period. The options vested in full in November 2018. Details of the exercises
are shown in the table below.
Brian Tenner, CEO, and Nigel Pickett, CTO, have both exercised their
respective awards and utilised the cash proceeds of selling a proportion of
shares to fund their personal tax obligations and dealing fees, while
retaining the balance in full thereby increasing their shareholdings by
551,946 shares and 498,336 shares respectively.
Application was made to the FCA for the 1,985,206 new Ordinary Shares to be
admitted to the premium segment of the Official List and to the London Stock
Exchange for the new Ordinary Shares to be admitted to trading on its main
market for listed securities. Admission became effective on 27 July 2023, and
dealings in the new Ordinary Shares have now commenced. The new Ordinary
Shares rank pari passu in all respects with the existing Ordinary Shares.
Following Admission, the Company's issued share capital comprised 324,430,950
Ordinary Shares, of which 12,222 were previously held in treasury and remain
so. Each Ordinary Share carries the right to one vote and, therefore, the
total number of voting rights in the Company on Admission will be 324,418,728.
This figure may be used by Shareholders and other investors as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
The details of the awards and subsequent exercise and retention of shares are
as follows:
Name of Director / PDMR Number of options exercised Number of shares sold to meet tax and fee obligations Shares retained following exercise Total shareholding
Brian Tenner (CEO - Director) - 2019 award 1,043,268 (491,322) 551,946 1,157,834
Dr Nigel Pickett (CTO - Director) 2019 award 875,362 (412,248) 463,114 11,770,911
Dr Nigel Pickett (CTO - Director) 2016 award 66,576 (31,354) 35,222 (inc above)
This notification is made pursuant to the Disclosure and Transparency Rules.
For further information please contact:
Liam Gray
Chief Financial Officer and Company Secretary
Telephone : +44 (0) 1928 761422
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are
materials with dimensions typically in the range 1 - 100 nm. Nano-materials
have a range of useful properties, including optical and electronic. Quantum
dots are a subclass of nano-material that have size-dependent optical and
electronic properties. The Group produces quantum dots and other
nano-materials. Within the sphere of quantum dots, the Group exploits
different characteristics of the quantum dots to target different performance
criteria that are attractive to specific markets or end-user applications such
as the Display, Sensor and Electronics markets. An interesting property of
quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots
can be tuned to absorb light at different wavelengths across the near-infrared
spectrum, rendering them useful for applications including image sensors.
Another interesting property of quantum dots is photoluminescence: the
emission of longer wavelength light upon excitation by light of a shorter
wavelength. The colour of light emitted depends on the particle size. Nanoco's
CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can
be tuned to emit light at different wavelengths across the visible and
infrared spectrum, rendering them useful for a wide range of applications
including displays, lighting and biological imaging.
Nanoco was founded in 2001 and is headquartered in Runcorn, UK, with a US
subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a
world-class, patent-protected IP portfolio generated both by its own
innovation engine, as well as through acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange and trades
under the ticker symbol NANO. For further information please visit:
www.nanocotechnologies.com.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibilities ("PDMR") /
person closely associated with them ("PCA")
a) Name BRIAN TENNER
2. Reason for the notification
a) Position /status CHIEF EXECUTIVE OFFICER
b) Initial notification / amendment INITIAL NOTIFICATION
3. Details of the Issuer
a) Name NANOCO GROUP PLC
b) LEI code 213800HOSJEZO1KOCV33
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Type of instrument ORDINARY SHARES OF 1O PENCE EACH
Identification code
ISIN: GB00B01JLR99
b) Nature of the transaction EXERCISE OF AN OPTION OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED
BONUS PLAN AND SALE OF SUFFICIENT SHARES TO FUND INCOME TAX AND NATIONAL
INSURANCE CHARGES. BALANCE RETAINED.
c) Price(s) and volume(s) Price(s) Volume(s)
Acquisition of shares on
exercise of option Nil cost 1,043,268
Sale of shares to pay tax and costs
18p 491,322
d) Aggregated information: N/A
- Aggregated volume
- Price
e) Date of the transaction 28 JULY 2023
f) Place of the transaction LONDON STOCK EXCHANGE, MAIN MARKET
d)
Aggregated information:
- Aggregated volume
- Price
N/A
e)
Date of the transaction
28 JULY 2023
f)
Place of the transaction
LONDON STOCK EXCHANGE, MAIN MARKET
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibilities ("PDMR") /
person closely associated with them ("PCA")
a) Name DR NIGEL PICKETT
2. Reason for the notification
a) Position /status CHIEF TECHNICAL OFFICER
b) Initial notification / amendment INITIAL NOTIFICATION
3. Details of the Issuer
a) Name NANOCO GROUP PLC
b) LEI code 213800HOSJEZO1KOCV33
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Type of instrument ORDINARY SHARES OF 1O PENCE EACH
Identification code
ISIN: GB00B01JLR99
b) Nature of the transaction EXERCISE OF AN OPTION OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED
BONUS PLAN AND SALE OF SUFFICIENT SHARES TO FUND INCOME TAX AND NATIONAL
INSURANCE CHARGES. BALANCE RETAINED.
c) Price(s) and volume(s) Price Volume
Acquisition of shares on Nil cost 875,362
exercise of option
Acquisition of shares on
exercise of option Nil cost 66,576
Sale of shares to pay tax and costs 18p 443,602
d) Aggregated information: N/A
- Aggregated volume
- Price
e) Date of the transaction 28 JULY 2023
f) Place of the transaction LONDON STOCK EXCHANGE, MAIN MARKET
= END =
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHNKFBBABKDBOB